Fundraising Fox
/Companies
Sign in

Akebia Therapeutics

Cambridge, US · Founded 2007 · 255 employees on LinkedIn · 2 known investors

Find your way into Akebia Therapeutics

Sign up to see every warm intro you have to Akebia Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Akebia Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.

BiotechHealthtechMedical Devices

Founders & leadership

JPJohn P. Butler
John P. ButlerPresident and Chief Executive Officer

Investors · 2

Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M

How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Founder mafia

3 people who came through Akebia Therapeutics went on to found or lead other companies.

Jodie MorrisonBoard MemberFounded Q32 BioJohn RiceFounder, Board of Directors and past ChairmanFounded Airway-TherapeuticsJoseph GardnerPresident & CEOFounded Aerpio Therapeutics

Related companies · 4

RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.

Companies working in the same space as Akebia Therapeutics.

Frequently asked questions

What does Akebia Therapeutics do?
Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.
Who are Akebia Therapeutics's investors?
Akebia Therapeutics's investors include CincyTech, Longitude Capital.
Where is Akebia Therapeutics headquartered?
Akebia Therapeutics is headquartered in Cambridge, US.